131 related articles for article (PubMed ID: 38862663)
1. QbD Assisted Systematic Review for Optimizing the Selection of PVP as a Ternary Substance in Enhancing the Complexation Efficiency of Cyclodextrins: a Pilot Study.
Mulenga G; Alahmed TAA; Sami F; Majeed S; Ali MS; Le JLJ; Rhu CLQ; Nair RS; Hasan N; Ansari MT
AAPS PharmSciTech; 2024 Jun; 25(5):134. PubMed ID: 38862663
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
Jablan J; Szalontai G; Jug M
J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
[TBL] [Abstract][Full Text] [Related]
4. Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes.
Sami F; Philip B; Pathak K
AAPS PharmSciTech; 2010 Mar; 11(1):27-35. PubMed ID: 20013079
[TBL] [Abstract][Full Text] [Related]
5. Effect of PVP K-25 on the formation of the naproxen:beta-ciclodextrin complex.
Valero M; Pérez-Revuelta BI; Rodríguez LJ
Int J Pharm; 2003 Mar; 253(1-2):97-110. PubMed ID: 12593941
[TBL] [Abstract][Full Text] [Related]
6. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
Mura P; Faucci MT; Bettinetti GP
Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
[TBL] [Abstract][Full Text] [Related]
7. Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions.
Zoeller T; Dressman JB; Klein S
Int J Pharm; 2012 Jul; 430(1-2):176-83. PubMed ID: 22531855
[TBL] [Abstract][Full Text] [Related]
8. Formulation of Curcumin-β-cyclodextrin-polyvinylpyrrolidone supramolecular inclusion complex: experimental, molecular docking, and preclinical anti-inflammatory assessment.
Jafar M; Khalid MS; Aldossari MFE; Amir M; Alshaer FI; Adrees FAA; Gilani SJ; Alshehri S; Hassan MZ; Imam SS
Drug Dev Ind Pharm; 2020 Sep; 46(9):1524-1534. PubMed ID: 32808552
[TBL] [Abstract][Full Text] [Related]
9. Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD.
Granero G; de Bertorello MM; Longhi M
Boll Chim Farm; 2002; 141(1):63-6. PubMed ID: 12064060
[TBL] [Abstract][Full Text] [Related]
10. Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology.
Lu Y; Tang N; Qi J; Wu W
Pharm Dev Technol; 2012; 17(2):236-41. PubMed ID: 21067338
[TBL] [Abstract][Full Text] [Related]
11. Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
Orienti I; Cerchiara T; Zecchi V; Arias Blanco MJ; Gines JM; Moyano JR; Rabasco Alvarez AM
Int J Pharm; 1999 Nov; 190(2):139-53. PubMed ID: 10547454
[TBL] [Abstract][Full Text] [Related]
12. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
Smith JS; Macrae RJ; Snowden MJ
Eur J Pharm Biopharm; 2005 May; 60(1):73-80. PubMed ID: 15848059
[TBL] [Abstract][Full Text] [Related]
13. Electrospun formulation of acyclovir/cyclodextrin nanofibers for fast-dissolving antiviral drug delivery.
Celebioglu A; Uyar T
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111514. PubMed ID: 33255070
[TBL] [Abstract][Full Text] [Related]
14. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
15. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
Liu B; Li W; Nguyen TA; Zhao J
Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
[TBL] [Abstract][Full Text] [Related]
16. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
17. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
18. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
[TBL] [Abstract][Full Text] [Related]
20. The role of L-arginine in inclusion complexes of omeprazole with cyclodextrins.
Figueiras A; Sarraguça JM; Pais AA; Carvalho RA; Veiga JF
AAPS PharmSciTech; 2010 Mar; 11(1):233-40. PubMed ID: 20135244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
